pharmacology exam 2 fml kms not live laugh loving

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/753

encourage image

There's no tags or description

Looks like no tags are added yet.

754 Terms

1
New cards

glaucoma

group of ocular disorders characterized by changes in optic disk and loss of visual sensitivity and field


intraocular pressure is not part of current diagnostic criteria

2
New cards

glaucoma common in who

second cause of blindness

increases with age

more common in blacks

3
New cards

cause of glaucoma

build up of fluid (aqueous humor) in eye

increase pressure of anterior chamber

4
New cards

aqueous humor exits out of where

ciliary to anterior chamber

5
New cards

conventional route of aqueous humor removal

trabecular outflow

80-85%

6
New cards

nonconventional rout of aqueous humor removal

uveoscleral outflow

15-20

7
New cards

drugs to increase outflow of aqueous humor removal

should target conventional and non conventional

drugs should not target the same thing

most drugs target conventional

8
New cards

risk factors of glaucoma

IOP > 30 mmHg

suspicious optic disk fittings

FH

systemic vascular disease

increased age

asymmetric cups

high myopia

optic disk hemorrhages

increasing IOP over time or Increase/decrease of IOP

retinal nerve fiber defects

TII DM

african american or hispanic

9
New cards

optic disc cupping in glaucoma

an enlargement/deepening of the normal depression in the center of the optic disc due to loss of retinal ganglion cell axons.

risk factor of glaucoma

10
New cards

range of cupping

normal → mild → severe

11
New cards

asymmetric cupping

one eye has more cupping than another

12
New cards

open angle glaucoma

is a gradual, usually painless loss of peripheral vision caused by impaired aqueous humor drainage, increased intraocular pressure, and progressive optic nerve damage.

13
New cards

closed angle glaucoma

occurs when the iris blocks the drainage angle, causing a rapid increase in intraocular pressure that can lead to severe eye pain, headache, blurred vision, halos, nausea/vomiting, and optic nerve damage.

14
New cards

low risk medications for open angle glaucoma

systemic anticholinergics

heterocyclic antidepressants

phenothiazines

vasodilators

cimetidine

15
New cards

low risk medications for closed angle glaucoma

antihistamines

systemic anticholinergics

heterocyclic antidepsressents

phenothiazines

ipratropium

benzodiazepines

16
New cards

high risk medications for open angle glaucoma

corticosteroids

topical anticholinergics

17
New cards

high risk medications for closed angle glaucoma

topical anticholinergics

topical sympathomimetics

18
New cards

main drugs that risk glaucoma

antihistamines and anticholinergics

19
New cards

goals of therapy for glaucoma

lower IOP to a level associated with a decreased risk of optic nerve damage

approximately 25-30% - depends on situation tho

20
New cards

therapeutic approach starting with how many eyes

start in one eye to see if it works or if there are adverse effects

start in both eyes if very high IOP or advanced field loss

21
New cards

therapeutic approach drug concentrations

start with low concentrations of a single agent

22
New cards

when two eye drops are being used how is that done

instillation should be separated by at lease 3-5 minutes, ideally 10, because the eye can only hold one drop at a time

23
New cards

therapeutic approach monitoring

monitors for 2-4 weeks then every 3-4 months once IOP reaches an acceptable range

24
New cards

nasolacrimal occulsion

blockage of the nasolacrimal duct, preventing tears from draining from the eye into the nose and causing excessive tearing (epiphora).

25
New cards

how should the eye drops be administered

with nasolacrimal occlusion to improve absorption and bioavailbility

26
New cards

what kind of medicine is used in the start of glaucoma

beta blocker or prostaglandin analogue

27
New cards

alternative first line agent if contraindications to first line agent

brimonidine

28
New cards

after the start of therapy how long do you wait to asses

2-4 weeks

29
New cards

if there is an inadequate response to the first medicine what do you do

ensure compliance/administration technique

increase concentration if possible or increase frequency

switch to an alternative first line agent if no response or add a second first line agent if partial response

30
New cards

if there is intolerance to the first line response what do you

reduce the concentration if possible or

change the formulations or

switch to an alternative class or

switch to an alternative combination

31
New cards

after adjustment of drugs how long do you wait to assess

2-4 weeks

32
New cards

if there is a second inadequate response what do you do

ensure compliance

if no response try an alternative first line topical agent

if partial response add a second or third first line agent or topical CAI

33
New cards

if there is an intolerance after the first change of drugs what do you do

reduce the concentration if possible or

change the formulations or

switch to an alternative class or

switch to an alternative combination

34
New cards

after changing the drugs the second time how long do you wait before assessing

2-4 weeks

35
New cards

if there is another inadequate response (3rd) what do you do

ensure compliance

consider adding direct acting cholinergic agent or cholinesterase inhibitor

consider adding oral CAI in place of topical CAI

36
New cards

if there is another intolerance (3rd) what do you do

reduce the concentration if possible or

change the formulations or

switch to an alternative class or

switch to an alternative combination

37
New cards

after waiting another 2-4 weeks what do you do

if intolerance or inadequate response to maximally tolerated combination drug therapy persists consult to laser or surgical

38
New cards

therapeutic options for glaucoma

topical beta blockers

prostaglandin analogues

alpha andrenergic inhibitors

carbonic anhydrase inhibitors

topical parasympathomimetic agents - direct cholinergic agonist

cholinesterase inhibitors

39
New cards

topical beta blocker MOA

reduce IOP by decreasing the production of aqueous humor by the ciliary body without affecting aqueous humor outflow

40
New cards

topical beta blockers reduce IOP by what

20-25%

41
New cards

topical beta blocker local ADE

stinging

dry eyes

corneal anesthesia

blepharitis

blurred vision

conjunctivitis

uveitis

keratitis

42
New cards

stinging ADE from beta blockers is found in use of what drugs

betaxolol and metipranolol

43
New cards

system ADE of topical beta blockers

drugs may be absorbed and produce system effects

bradycardia

hypotension

bronchospasm

blocking symptoms of hypoglycemia

CNS effects

44
New cards

bronchospasms are seen with what topical beta blocker

non-selective beta blockers

45
New cards

what part of the eye do topical beta blockers act on

ciliary to produce less aqueous humor

46
New cards

kinds of beta blockers

betaxolol

carteolol

levobunolol

metipranolol

timolol

47
New cards

betaxolol is what kind of gluacoma drug

topical beta blocker

48
New cards

carteolol is what kind of gluacoma drug

topical beta blocker

49
New cards

levobunolol is what kind of gluacoma drug

topical beta blocker

50
New cards

metipranolol is what kind of gluacoma drug

topical beta blocker

51
New cards

timolol is what kind of gluacoma drug

topical beta blocker

52
New cards

when are topical beta blockers used

start of therapy

preferred first drug used

53
New cards

prostaglandin analogues MOA

increasing uveoscleral outflow (non-conventional route) of aqueous humor

54
New cards

analogue

a compound with a structure similar to another compound differing in specific atoms, functional groups, or substructures

55
New cards

prostaglandin analogues reduce IOP by what

25-35%

56
New cards

prostaglandin analogues are effective in what concentrations

low concentrations

57
New cards

prostaglandin analogues used in combination or not

may be used in combination

58
New cards

prostaglandin analogues ADEs

increased frequency of punctate corneal erosions

increased frequency of conjunctival hyperemia

iris hyperpigmentation

increased eyelash growth

59
New cards

what eye structure do prostaglandin analogues effect

uveoscleral outflow

60
New cards

prostaglandin analogues drugs

iatanoprost

bimatoprost

travoprost

61
New cards

latanoprost is what kind of glaucoma drug

prostaglandin analogue

62
New cards

bimatoprost is what kind of glaucoma drug

prostaglandin analogue

63
New cards

travoprost is what kind of glaucoma drug

prostaglandin analogue

64
New cards

when are prostaglandin analogues used in the glaucoma treatment algorithm

at the start of therapy or after assessment

65
New cards

alpha adrenergic agonist MOA

decrease ciliary body production of aqueous humor or increase in uveoscleral aqueous humor outflow

66
New cards

alpha adrenergic agonist reduces IOP by what

20-25%

67
New cards

how to use alpha adrenergic agonist with beta blockers

should be separated by more than 3 hours

68
New cards

alpha adrenergic agonists local ADEs

tearing

burning

ocular discomfort

browache

conjunctival hyperemia

blurred vision

discoloration of soft contact lenses

mydriasis

deposition of adrenochrome pigment in conjunctiva or cornea

69
New cards

alpha adrenergic agonist systemic ADEs

headache

faintness

hypotension

tachycardia

arrhythmias

tremor

pallor

70
New cards

alpha adrenergic agonist work on what part of the eye

ciliary body

71
New cards

kinds of alpha adrenergic agonists

epinephrine HCl

epinephrine bitartrate

dipivefrin

aparaclonidine

brimonidine

brimonidine/timolol

72
New cards

epinephrine HCl is what kind of glaucoma drug

alpha adrenergic agonist

73
New cards

epinephrine bitartrate is what kind of glaucoma drug

alpha adrenergic agonist

74
New cards

dipivefrin is what kind of glaucoma drug

alpha adrenergic agonist

75
New cards

apraclonidine is what kind of glaucoma drug

alpha adrenergic agonist

76
New cards

brimonidine is what kind of glaucoma drug

alpha adrenergic agonist

77
New cards

brimonidine/timolol is what kind of glaucoma drug

alpha adrenergic agonist and beta blocker combo

78
New cards

when are alpha adrenergic agonist used in the glaucoma treatment algorithm

alternative first line agent

or after the first assessment for inadequate response

79
New cards

carbonic anhydrase inhibitors MOA

decreases IOP by decreasing ciliary body aqueous humor secretion by 40-60%

active secretion of sodium and bicarbonate may produce an osmotic gradient resulting in transfer of water from the ciliary body to aqueous humor

80
New cards

carbonic anhydrase inhibitors reduce IOP by what

15-20% - topical

20-30% - oral products

81
New cards

carbonic anhydrase inhibitors in combination

may provide additive effect with beta blockers and cholinergic agents

82
New cards

when should carbonic anhydrase inhibitors be avoided

with sulfa allergy because it contains sulfonamide moieties

83
New cards

when are oral carbonic anhydrase inhibitors used

in patients failing to respond to or tolerate maximum topical therapy

84
New cards

carbonic anhydrase inhibitors local ADE

frequent transient burning or stinging

ocular discomfort

blurred vision

tearing

conjuctivitis

photophobia

85
New cards

carbonic anhydrase inhibitors systemic ADE

malaise

fatigue

anorexia

nausea

weight loss

altered taste

depression

decreased libido

86
New cards

carbonic anhydrase inhibitors acts on what eye part

ciliary

87
New cards

carbonic anhydrase inhibitors topical drugs

dorzolamide

brinzolamide

dorzolamide/timolol

brinzolamide/brimonidine

88
New cards

dorzolamide is what kind of gluacoma drug

topical carbonic anhydrase inhibitors

89
New cards

brinzolamide is what kind of gluacoma drug

topical carbonic anhydrase inhibitors

90
New cards

dorzolamide/timolol is what kind of gluacoma drug

topical carbonic anhydrase inhibitors

91
New cards

brinzolamide/brimonidine is what kind of gluacoma drug

topical carbonic anhydrase inhibitors

92
New cards

oral/IV carbonic anhydrase inhibitors drugs

acetazolamide

dichlorphenamide

methazolamide

93
New cards

acetazolamdie is what kind glaucoma drug

oral/IV carbonic anhydrase inhibitors drugs

94
New cards

dichlorphenamide is what kind glaucoma drug

oral carbonic anhydrase inhibitors drugs

95
New cards

methazolamide is what kind glaucoma drug

oral carbonic anhydrase inhibitors drugs

96
New cards

when is carbonic anhydrase inhibitors drugs used in glaucoma treatment algorithm

alternative first line agent when contraindication to a regular first line agent

97
New cards

topical parasympathomimetic agents MOA

reduce IOP by increasing aqueous humor trabecular outflow by opening the trabecular meshwork secondary to ciliary muscle contraction

98
New cards

topical parasympathomimetic agents reduce IOP how much

20-25%

99
New cards

topical parasympathomimetic agents and beta blockers

topical parasympathomimetic agents may enhance the effect of beta blockers

100
New cards

topical parasympathomimetic agents local ADE

miosis - decrease night vision

accommodative spasm

frontal headache

peri-orbital pain

eyelid twitching

conjunctival irritation